BRWRX
Price
$20.31
Change
-$1.33 (-6.15%)
Updated
Apr 3 closing price
Net Assets
391.91M
GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
Ad is loading...

BRWRX vs GFACX

Header iconBRWRX vs GFACX Comparison
Open Charts BRWRX vs GFACXBanner chart's image
MFS Blended Research Growth Eq R1
Price$20.31
Change-$1.33 (-6.15%)
VolumeN/A
Net Assets391.91M
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
BRWRX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BRWRX vs. GFACX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRWRX is a Hold and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 280B vs. BRWRX (392M). BRWRX (0.00) and GFACX (0.00) have matching dividends . BRWRX was incepted earlier than GFACX: BRWRX (10 years) vs GFACX (24 years). BRWRX (1.60) is less costly to investors than GFACX (1.36). BRWRX is a more actively managed with annual turnover of: 48.00 vs. GFACX (25.00). BRWRX has a lower initial minimum investment than GFACX: BRWRX (0) vs GFACX (250). BRWRX annual gain was more profitable for investors over the last year : 3.49 vs. GFACX (-1.75). BRWRX return over 5 years is better than : 76.22 vs. GFACX (59.73).
BRWRXGFACXBRWRX / GFACX
Total Expense Ratio1.491.36110%
Annual Report Gross Expense Ratio1.601.36118%
Fund Existence10 years24 years-
Gain YTD-8.730-5.003175%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets392M280B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year3.49-1.75-199%
Returns for 3 years21.370.633,385%
Returns for 5 years76.2259.73128%
Returns for 10 yearsN/A44.46-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences